Susquehanna International Group, LLP Larimar Therapeutics, Inc. Put Options Transaction History

Susquehanna International Group, LLP

  • $560 Billion
  • Q3 2024

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$6.3 - $10.68 $64,890 - $110,004
10,300 Added 28.14%
46,900 $307,000
Q2 2024

Aug 15, 2024
BUY
$6.33 - $9.89 $68,364 - $106,812
10,800 Added 41.86%
36,600 $265,000
Q1 2024

May 07, 2024
BUY
$4.2 - $13.28 $108,360 - $342,624
25,800 New
25,800 $195,000
Q3 2022

Nov 14, 2022
BUY
$1.53 - $3.64 $23,409 - $55,692
15,300 New
15,300 $49,000

Others Institutions Holding LRMR

# of Institutions
127
Shares Held
67.3M
Call Options Held
280K
Put Options Held
76.3K
View Full List

About Larimar Therapeutics, Inc.

LRMR Quotes by TradingView
  • Ticker LRMR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,269,200
  • Market Cap $155M
  • Description
  • Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 1 clinical trial for the treatment of Friedreich's ataxia, a rare, progressive, and fatal genetic disease. T...
More about LRMR
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email